血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤

2018-07-09 梅奥诊所 Bone Marrow Transplant. 2018 Jul 9.

造血干细胞移植多发性骨髓瘤

在过去的二十年里，出现各种新的治疗方法用于改善多发性骨髓瘤患者的生存。本文是由来自梅奥诊所超过30明多学科医生小组提供的关于造血干细胞移植（ASCT）治疗多发性骨髓瘤的共识声明，主要内容涉及ASCT治疗多发性骨髓瘤的作用和时机，ASCT后巩固和维持治疗，前端串联ASCT的效用，挽救性二次ASCT以及异基因造血干细胞移植等。

中文标题：

2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤

英文标题：

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

发布机构：

梅奥诊所

发布日期：

2018-07-09

简要介绍：

在过去的二十年里，出现各种新的治疗方法用于改善多发性骨髓瘤患者的生存。本文是由来自梅奥诊所超过30明多学科医生小组提供的关于造血干细胞移植（ASCT）治疗多发性骨髓瘤的共识声明，主要内容涉及ASCT治疗多发性骨髓瘤的作用和时机，ASCT后巩固和维持治疗，前端串联ASCT的效用，挽救性二次ASCT以及异基因造血干细胞移植等。 

拓展指南：与多发性骨髓瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤)] GetToolGuiderByIdResponse(projectId=1, id=80bf31c001615a4f, title=2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤, enTitle=Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement., guiderFrom=Bone Marrow Transplant. 2018 Jul 9., authorId=null, author=, summary=在过去的二十年里，出现各种新的治疗方法用于改善多发性骨髓瘤患者的生存。本文是由来自梅奥诊所超过30明多学科医生小组提供的关于造血干细胞移植（ASCT）治疗多发性骨髓瘤的共识声明，主要内容涉及ASCT治疗多发性骨髓瘤的作用和时机，ASCT后巩固和维持治疗，前端串联ASCT的效用，挽救性二次ASCT以及异基因造血干细胞移植等。 , cover=, journalId=null, articlesId=null, associationId=752, associationName=梅奥诊所, associationIntro=世界著名私立非营利性医疗机构，于1864年由梅奥医生在明尼苏达州罗切斯特市创建，是世界最具影响力和代表世界最高医疗水平的医疗机构之一，在医学研究领域处于领跑者地位。, copyright=0, guiderPublishedTime=Mon Jul 09 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>在过去的二十年里，出现各种新的治疗方法用于改善多发性骨髓瘤患者的生存。本文是由来自梅奥诊所超过30明多学科医生小组提供的关于造血干细胞移植（ASCT）治疗多发性骨髓瘤的共识声明，主要内容涉及ASCT治疗多发性骨髓瘤的作用和时机，ASCT后巩固和维持治疗，前端串联ASCT的效用，挽救性二次ASCT以及异基因造血干细胞移植等。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>多发性骨髓瘤</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=519f01c0016135c4" title="2018 ILROG指南：孤立性浆细胞瘤和多发性骨髓瘤放射治疗" target=_blank>2018 ILROG指南：孤立性浆细胞瘤和多发性骨髓瘤放射治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7fbbf1c00159ea01" title="多发性骨髓瘤骨病外科治疗循证医学指南" target=_blank>多发性骨髓瘤骨病外科治疗循证医学指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=64d2e1c00156324a" title="NCCN临床实践指南：多发性骨髓瘤（2018.V4）" target=_blank>NCCN临床实践指南：多发性骨髓瘤（2018.V4）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=31f191c00153a10d" title="2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理" target=_blank>2017 EMN共识：多发性骨髓瘤新药不良事件的预防和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9b91f1c00152ae45" title="2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读" target=_blank>2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%A4%9A%E5%8F%91%E6%80%A7%E9%AA%A8%E9%AB%93%E7%98%A4" target=_blank>有关多发性骨髓瘤更多指南</a></ul>, tagList=[TagDto(tagId=8486, tagName=造血干细胞移植), TagDto(tagId=321, tagName=多发性骨髓瘤)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7680, appHits=272, showAppHits=0, pcHits=4750, showPcHits=3554, likes=135, shares=8, comments=3, approvalStatus=1, publishedTime=Sat Jul 14 23:55:15 CST 2018, publishedTimeString=2018-07-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 14 23:55:15 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 05:03:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤)])
2018 mSMART共识声明：造血干细胞移植治疗多发性骨髓瘤
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=331775, encodeId=6cfa331e751a, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 15 11:54:13 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331693, encodeId=f0e833169312, content=学习了!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jul 15 06:33:56 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331677, encodeId=e4d13316e723, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jul 15 05:42:22 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-15 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=331775, encodeId=6cfa331e751a, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 15 11:54:13 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331693, encodeId=f0e833169312, content=学习了!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jul 15 06:33:56 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331677, encodeId=e4d13316e723, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jul 15 05:42:22 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-15 zb1235672

    学习了!!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=331775, encodeId=6cfa331e751a, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 15 11:54:13 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331693, encodeId=f0e833169312, content=学习了!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jul 15 06:33:56 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331677, encodeId=e4d13316e723, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jul 15 05:42:22 CST 2018, time=2018-07-15, status=1, ipAttribution=)]
    2018-07-15 yjs木玉

    学习学习再学习

    0

相关指南

2018 EBMT立场声明：造血干细胞移植后患者腺病毒感染的管理

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-04-16

《2017年意大利共识指南：血液系统恶性肿瘤以及接受造血干细胞移植患者HBV再激活的筛查、监测、预防和预防性治疗的建议》摘译

暂未更新 · 2017-11-15

2016 ECIL-5建议：血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01

2015 ASBMT指南：造血干细胞移植治疗多发性骨髓瘤

美国血液与骨髓移植学会(ASBMT,American Society for Blood and Marrow Transplantation) · 2015-03-10

中国异基因造血干细胞移植治疗血液系统疾病专家共识（Ⅰ）——适应证、预处理方案及供者选择（2014年版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2014-08-15